Cleared Traditional

K053553 - NYCOCARD U-ALBUMIN AND U-ALBUMIN CONTROL

K053553 is the FDA 510(k) clearance for NYCOCARD U-ALBUMIN AND U-ALBUMIN CONTROL by Polymedco, Inc.. It is a Class 2 Chemistry device (product code DCF) cleared through the Traditional 510(k) pathway after a 79-day FDA review.

K053553 · Polymedco, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2006
Decision
79d
Days
Class 2
Risk

K053553 is an FDA 510(k) clearance for the NYCOCARD U-ALBUMIN AND U-ALBUMIN CONTROL. Classified as Albumin, Antigen, Antiserum, Control (product code DCF), Class II - Special Controls.

Submitted by Polymedco, Inc. (Cortlandt Manor, US). The FDA issued a Cleared decision on March 9, 2006 after a review of 79 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 866.5040 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Polymedco, Inc. devices

Submission Details

510(k) Number K053553 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2005
Decision Date March 09, 2006
Days to Decision 79 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 88d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DCF Albumin, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5040
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DCF Albumin, Antigen, Antiserum, Control

All 24
Devices cleared under the same product code (DCF) and FDA review panel - the closest regulatory comparables to K053553.
COBAS 8000 MODULAR SERIES ANALYZER
K100853 · Roche Diagnostics Corp. · Sep 2010
SYNCHRON SYSTEMS MICROALBUMIN (MA) REAGENT, MODEL 475100
K082251 · Beckman Coulter, Inc. · Apr 2009
DIMENSION VISTA MICROALBUMIN FLEX REAGENT CARTRIDGE
K061990 · Dade Behring, Inc. · Sep 2006
DCL MICROALBUMIN ASSAY, MODEL 252-20
K051191 · Diagnostic Chemicals , Ltd. · Jul 2005
VITROS CHEMISTRY PRODUCT MALB REAGENT, CALIBRATOR KIT 24, MALB PERFORMANCE VERIFIERS I AND II
K042643 · Ortho-Clinical Diagnostics, Inc. · Nov 2004
DIMENSION MICROALBUMIN (MALB) FLEX REAGENT CARTRIDGE METHOD, CALIBRATOR, MODELS DF114, DC114
K033525 · Dade Behring, Inc. · Jan 2004